Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Assisted Reproduction
Significantly increased fertilization rates announced
July 21st, 2005
Halozyme Therapeutics, Inc. (HTI), a development stage biopharmaceutical company focused on the development and commercialization of recombinant human enzymes, and Reproductive Biology Associates, one of the leading IVF centers in the U.S., announced results from clinical trials showing increased fertilization rates in oocytes (eggs) that were treated with cumulase prior to in vitro fertilization (IVF) using the intracytoplasmic sperm injection (ICSI) procedure. The data were presented today by Z. Peter Nagy, MD, PhD, scientific and laboratory director of Reproductive Biology Associates in Atlanta, Georgia, at the 21st Annual Meeting of the European Society of Human...
Source: Women's Health Weekly (2005-07-21)
|
